The dysphoric syndrome in schizophrenia and its implications for relapse.
Hirsch
S R
SR
Department of Psychiatry, Charing Cross and Westminster Medical School, London.
Jolley
A G
AG
D000328:Adult; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000523:psychology*; D004311:Double-Blind Method; D005260:Female; D005476:Fluphenazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009497:Neurotic Disorders / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
C011825:fluphenazine depot; D005476:Fluphenazine